Beckman coulter offers $4/high-throughput antigen test to support u.s. government initiative to expand covid-19 testing

Brea, calif., march 18, 2021 /prnewswire/ -- beckman coulter, a clinical diagnostics leader, today announced their commitment to support the u.s. government's plan to invest more than $12 billion to expand covid-19 testing with their high-throughput, high-quality lab antigen test, access sars-cov-2 ag,* ideal for mass screening testing.
DHR Ratings Summary
DHR Quant Ranking